GTBP · GT Biopharma, Inc.
$0.29
-0.01 (-3.38%)
At close · Aug 17
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year of the date that the financial statements are issued. In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2025 financial statements, raised substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$12.86M
Shares
45.11M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-14 | ANNUAL MEETING OF STOCKHOLDERS | Shareholder meeting |
| 2026-03-24 | 38TH ANNUAL ROTH CONFERENCE | Conference |
| 2026-03-05 | CENTURION ONE CAPITAL 9TH ANNUAL TORONTO GROWTH CONFERENCE | Conference |
Source: https://ir.gtbiopharma.com/
Key facts
CIK
109657
CUSIP
36254L308
13F (30d)
48 filings
48 filers
Visit website
Investor relations